Perceptual Retraining to Reduce Suicide Risk
Completed · Not applicable · Has a placebo group
Conditions studied: Perceptual Olfactory Bias
In brief
The study will use a prospective design consisting of three phases. The phases are: 1. the development of the perceptual retraining treatment (PRT), 2. the evaluation of the treatment's feasibility and acceptability, and 3. an assessment of its efficacy. During the third phase, a pilot study will be conducted in which participants will be randomly assigned to either PRT or a waitlist control group in order to assess efficacy. Diagnostic information and eligibility criteria will be assessed using the Structured Clinical Interview for Diagnostic and Statistical Manual (DSM) 4th ed. (SCID) and the Clinician Administered PTSD Scale for DSM-5 (CAPS-5).
Key facts
- Study ID
- NCT02845700
- Run by
- Florida State University
- People needed
- 13
- Starts
- 2015-09-01
- Expected to finish
- 2016-09-01
- Last updated by the study team
- 2019-01-14
Who can join
Age: 18 and older, up to 60. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- evidence of olfactory perceptual bias toward military-relevant stimuli (e.g., burning rubber, decay, fuel).
- military combat exposure in Operation Iraqi Freedom, Enduring Freedom, or New Dawn.
- Age 18-60.
You may not qualify if…
- Significant medical illness that compromises olfactory perception or tolerance (e.g., significant olfactory disease or dysfunction, cardiovascular disease, respiratory disorders, renal disease, epilepsy, stroke, and uncontrolled hypertension or migraines).
- Evidence of imminent suicidal intent
- Evidence of current or past psychotic-spectrum disorders, or uncontrolled bipolar disorder.
- English speakers.
Where it is running
- Florida State University — Tallahassee, Florida, United States
- Southeast Louisiana Veterans Health Care System — New Orleans, Louisiana, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.